{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:02:27Z","timestamp":1786978947234,"version":"build-2736575974"},"publisher-location":"Cham","reference-count":64,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319080598","type":"print"},{"value":"9783319080604","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-319-08060-4_13","type":"book-chapter","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T00:30:30Z","timestamp":1407371430000},"page":"189-201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Early and Late Toxicity of Radiotherapy for Rectal Cancer"],"prefix":"10.1007","author":[{"given":"Ines","family":"Joye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Haustermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,8]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.ejca.2012.09.026","volume":"49","author":"X An","year":"2013","unstructured":"An X, Lin X, Wang FH et al (2013) Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis. Eur J Cancer 49:843\u2013851","journal-title":"Eur J Cancer"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343\u20132351","journal-title":"N Engl J Med"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(13)61648-7","volume":"382","author":"HJ Andreyev","year":"2013","unstructured":"Andreyev HJ, Benton BE, Lalji A et al (2013) Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial. Lancet 382:2084\u20132092","journal-title":"Lancet"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1200\/JCO.2010.34.4911","volume":"29","author":"C Aschele","year":"2011","unstructured":"Aschele C, Cionini L, Lonardi S et al (2011) Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomised phase III trial. J Clin Oncol 29:2773\u20132780","journal-title":"J Clin Oncol"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jvs.2004.08.031","volume":"40","author":"MO Baerlocher","year":"2004","unstructured":"Baerlocher MO, Rajan DK, Ing DJ, Rubin BB (2004) Primary stenting of bilateral radiation-induced external iliac stenoses. J Vasc Surg 40:1028\u20131031","journal-title":"J Vasc Surg"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nrc1950","volume":"6","author":"SM Bentzen","year":"2006","unstructured":"Bentzen SM (2006) Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 6:702\u2013713","journal-title":"Nat Rev Cancer"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"8697","DOI":"10.1200\/JCO.2005.02.9017","volume":"23","author":"H Birgisson","year":"2005","unstructured":"Birgisson H, P\u00e5hlman L, Gunnarson U, Glimelius B (2005a) Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23:8697\u20138705","journal-title":"J Clin Oncol"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"6126","DOI":"10.1200\/JCO.2005.02.543","volume":"23","author":"H Birgisson","year":"2005","unstructured":"Birgisson H, P\u00e5hlman L, Gunnarsson U, Glimelius B (2005b) Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 23:6126\u20136131","journal-title":"J Clin Oncol"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bjs.5918","volume":"95","author":"H Birgisson","year":"2008","unstructured":"Birgisson H, P\u00e5hlman L, Gunnarson U, Glimelius B (2008) Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy. Br J Surg 95:206\u2013213","journal-title":"Br J Surg"},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"JF Bosset","year":"2006","unstructured":"Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114\u20131123","journal-title":"N Engl J Med"},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1200\/JCO.2007.15.3858","volume":"26","author":"M Br\u00e6ndengen","year":"2008","unstructured":"Br\u00e6ndengen M, Tveit KM, Berglund A et al (2008) Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 26:3687\u20133694","journal-title":"J Clin Oncol"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ijrobp.2010.07.007","volume":"81","author":"M Br\u00e6ndengen","year":"2011","unstructured":"Br\u00e6ndengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund \u00c5, Glimelius B (2011) Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study. Int J Radiat Oncol Biol Phys 81:1017\u20131024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.ejca.2011.06.035","volume":"48","author":"M Br\u00e6ndengen","year":"2012","unstructured":"Br\u00e6ndengen M, Tveit KM, Hjermstad MJ et al (2012) Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III study. Eur J Cancer 48:813\u2013819","journal-title":"Eur J Cancer"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/bjs.5506","volume":"93","author":"K Bujko","year":"2006","unstructured":"Bujko K, Nowacki M, Nasierwska-Guttmejer A et al (2006) Long-term results of a randomised trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215\u20131223","journal-title":"Br J Surg"},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.radonc.2003.12.006","volume":"72","author":"K Bujko","year":"2004","unstructured":"Bujko K, Nowacki M, Nasierwska-Guttmejer A et al (2004) Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy versus conventionally fractionated radiochemotherapy. Radiother Oncol 72:15\u201324","journal-title":"Radiother Oncol"},{"key":"13_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1748-717X-5-31","volume":"5","author":"I Chitapanarux","year":"2010","unstructured":"Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S, Tharavichitkul E, Lorvidhaya V (2010) Randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol 5:31","journal-title":"Radiat Oncol"},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0037-198X(05)80072-0","volume":"29","author":"VP Chuang","year":"1994","unstructured":"Chuang VP (1994) Radiation-induced arteritis. Semin Roentgenol 29:64\u201369","journal-title":"Semin Roentgenol"},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/BF02235256","volume":"41","author":"M Dahlberg","year":"1998","unstructured":"Dahlberg M, Glimelius B, Graf W, P\u00e5hlman L (1998) Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum 41:543\u2013549","journal-title":"Dis Colon Rectum"},{"issue":"Suppl 2","key":"13_CR19","first-page":"1","volume":"93","author":"P Delia","year":"2007","unstructured":"Delia P, Sansotta G, Donato V et al (2007) Use of probiotics for prevention of radiation-induced diarrhea. Tumori 93(Suppl 2):1\u20136","journal-title":"Tumori"},{"key":"13_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0360-3016(00)00708-2","volume":"48","author":"JW Denham","year":"2000","unstructured":"Denham JW, Hauer-Jensen M, Kron T, Langberg CW (2000) Treatment-time-dependence models of early and delayed radiation injury in rat small intestine. Int J Radiat Oncol Biol Phys 48:871\u2013887","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13_CR21","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1200\/JCO.2011.39.6036","volume":"30","author":"A Dewdney","year":"2012","unstructured":"Dewdney A, Cunningham D, Tabernero J et al (2012) Multicenter randomised phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C). J Clin Oncol 30:1620\u20131627","journal-title":"J Clin Oncol"},{"key":"13_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0167-8140(01)00429-7","volume":"61","author":"W D\u00f6rr","year":"2001","unstructured":"D\u00f6rr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61:223\u2013231","journal-title":"Radiother Oncol"},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00066-005-1457-9","volume":"181","author":"W D\u00f6rr","year":"2005","unstructured":"D\u00f6rr W, Bertmann S, Hermann T (2005) Radiation induced lung reactions in breast cancer therapy. Modulating factors and consequential effects. Strahlenther Onkol 181:567\u2013573","journal-title":"Strahlenther Onkol"},{"key":"13_CR24","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.cgh.2012.07.017","volume":"10","author":"L Fuccio","year":"2012","unstructured":"Fuccio L, Guida A, Andreyev HJ (2012) Management of intestinal complications in patients with pelvic radiation disease. Clin Gastroenterol Hepatol 10:1326\u20131334","journal-title":"Clin Gastroenterol Hepatol"},{"key":"13_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0167-8140(95)01665-1","volume":"38","author":"GJ Frykholm","year":"1996","unstructured":"Frykholm GJ, Sintorn K, Montelius A, Jung B, P\u00e5hlman L, Glimelius B (1996) Early lumbosacral plexopathy during and after preoperative radiotherapy of rectal adenocarcinoma. Radiother Oncol 38:121\u2013130","journal-title":"Radiother Oncol"},{"key":"13_CR26","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","volume":"24","author":"JP G\u00e9rard","year":"2006","unstructured":"G\u00e9rard JP, Conroy T, Bonnetain F et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620\u20134625","journal-title":"J Clin Oncol"},{"key":"13_CR27","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1200\/JCO.2009.25.8376","volume":"28","author":"JP G\u00e9rard","year":"2010","unstructured":"G\u00e9rard JP, Azria D, Gourgou-Bourgade S et al (2010) Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12\/0405-Prodige 2. J Clin Oncol 28:1638\u20131644","journal-title":"J Clin Oncol"},{"key":"13_CR28","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1200\/JCO.2012.42.8771","volume":"30","author":"JP G\u00e9rard","year":"2012","unstructured":"G\u00e9rard JP, Azria D, Gourgou-Bourgade S et al (2012) Clinical outcome of the ACCORD 12\/0405 PRODIGE 2 randomised trial in rectal cancer. J Clin Oncol 30:4558\u20134565","journal-title":"J Clin Oncol"},{"key":"13_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1200\/JCO.2004.09.046","volume":"22","author":"RM Goldberg","year":"2004","unstructured":"Goldberg RM, Sargent DJ, Morton RF et al (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23\u201330","journal-title":"J Clin Oncol"},{"key":"13_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.radonc.2009.04.007","volume":"92","author":"P Hatfield","year":"2009","unstructured":"Hatfield P, Hingorani M, Radhakrishna G et al (2009) Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. Radiother Oncol 92:210\u2013214","journal-title":"Radiother Oncol"},{"key":"13_CR31","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/S0140-6736(86)91510-2","volume":"1","author":"RJ Heald","year":"1986","unstructured":"Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479\u20131482","journal-title":"Lancet"},{"key":"13_CR32","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<968::AID-CNCR5>3.0.CO;2-8","volume":"78","author":"T Holm","year":"1996","unstructured":"Holm T, Singnomklao T, Rutqvist LE, Cedermark B (1996) Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials. Cancer 78:968\u2013976","journal-title":"Cancer"},{"key":"13_CR33","doi-asserted-by":"crossref","DOI":"10.1201\/b15450","volume-title":"Basic Clinial Radiobiology","author":"M Joiner","year":"2009","unstructured":"Joiner M, van der Kogel A (2009) Basic Clinial Radiobiology. Hodder Arnold, London"},{"key":"13_CR34","doi-asserted-by":"crossref","unstructured":"Kapiteijn E, Marijnen CA, Nagtegaal ID et al., Dutch Colorectal Cancer Group (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638\u2013646","DOI":"10.1056\/NEJMoa010580"},{"key":"13_CR35","doi-asserted-by":"crossref","unstructured":"Marijnen CA, Kapiteijn E, van de Velde CJ et al., Cooperative Investigators of the Dutch Colorectal Cancer Group (2002) Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 20:817\u2013825","DOI":"10.1200\/JCO.2002.20.3.817"},{"key":"13_CR36","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1200\/JCO.2005.05.256","volume":"23","author":"CA Marijnen","year":"2005","unstructured":"Marijnen CA, van de Velde CJ, Putter H et al (2005) Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomised trial. J Clin Oncol 23:1847\u20131858","journal-title":"J Clin Oncol"},{"key":"13_CR37","doi-asserted-by":"crossref","unstructured":"Marquardt F, R\u00f6del F, Capalbo G, Weiss C, R\u00f6del C. (2009) Molecular targeted treatment and radiation therapy for rectal cancer. Strahlenther Onkol 185:371\u2013378","DOI":"10.1007\/s00066-009-1936-5"},{"key":"13_CR38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/1097-0142(20010815)92:4<896::AID-CNCR1398>3.0.CO;2-R","volume":"92","author":"A Martling","year":"2001","unstructured":"Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B (2001) The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 92:896\u2013902","journal-title":"Cancer"},{"key":"13_CR39","doi-asserted-by":"crossref","unstructured":"Ngan S, Fisher R, Mackay J et al (2007) Early adverse events in a randomised trial of short course versus long course preoperative radiotherapy for T3 adenocarcinoma of rectum: a trans-tasman radiation oncology group trial (TROG01.04). Eur J Cancer 5:237(Abstract)","DOI":"10.1016\/S1359-6349(07)70936-9"},{"key":"13_CR40","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","volume":"30","author":"SY Ngan","year":"2012","unstructured":"Ngan SY, Burmeister B, Fisher RJ et al (2012) Randomised trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: trans-tasman radiation oncology group trial 01.04. J Clin Oncol 30:3827\u20133833","journal-title":"J Clin Oncol"},{"key":"13_CR41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1471-2407-13-279","volume":"13","author":"PJ Nilsson","year":"2013","unstructured":"Nilsson PJ, van Etten B, Hospers GA et al (2013) Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer\u2013the RAPIDO trial. BMC Cancer 13:279","journal-title":"BMC Cancer"},{"key":"13_CR42","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2005.14.779","volume":"23","author":"KC Peeters","year":"2005","unstructured":"Peeters KC, van de Velde CJ, Leer JW et al (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients\u2013a Dutch colorectal cancer group study. J Clin Oncol 23:6199\u20136206","journal-title":"J Clin Oncol"},{"key":"13_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","volume":"246","author":"KC Peeters","year":"2007","unstructured":"Peeters KC, Marijnen CA, Nagtegaal ID et al (2007) The TME trial after a median follow-up of 6\u00a0years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693\u2013701","journal-title":"Ann Surg"},{"key":"13_CR44","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/bjs.6914","volume":"97","author":"D Pettersson","year":"2010","unstructured":"Pettersson D, Cedermark B, Holm T et al (2010) Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 97:580\u2013587","journal-title":"Br J Surg"},{"key":"13_CR45","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/bjs.7796","volume":"99","author":"D Pettersson","year":"2012","unstructured":"Pettersson D, Holm T, Iversen H, Blomqvist L, Glimelius B, Martling A (2012) Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg 99:577\u2013583","journal-title":"Br J Surg"},{"key":"13_CR46","doi-asserted-by":"crossref","unstructured":"Pietrzak L, Bujko K, Nowacki MP et al., Polish Colorectal Study Group (2007) Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. Radiother Oncol 84:217\u201325","DOI":"10.1016\/j.radonc.2007.07.007"},{"key":"13_CR47","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/bjs.5525","volume":"93","author":"J Pollack","year":"2006","unstructured":"Pollack J, Holm T, Cedermark B et al (2006a) Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg 93:1519\u20131525","journal-title":"Br J Surg"},{"key":"13_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10350-005-0296-1","volume":"49","author":"J Pollack","year":"2006","unstructured":"Pollack J, Holm T, Cedermark B, Holmstr\u00f6m B, Mellgren A (2006b) Long-term effect of preoperative radiation therapy on anorectal function. Dis Colon Rectum 49:345\u2013352","journal-title":"Dis Colon Rectum"},{"key":"13_CR49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.radonc.2007.11.025","volume":"87","author":"C Radu","year":"2008","unstructured":"Radu C, Berglund A, P\u00e5hlman L, Glimelius B (2008) Short-course preoperative radiotherapy with delayed surgery in rectal cancer - a retrospective study. Radiother Oncol 87:343\u2013349","journal-title":"Radiother Oncol"},{"key":"13_CR50","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1470-2045(12)70187-0","volume":"13","author":"C R\u00f6del","year":"2012","unstructured":"R\u00f6del C, Liersch T, Becker H et al (2012) Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial. Lancet Oncol 13:679\u2013687","journal-title":"Lancet Oncol"},{"key":"13_CR51","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","volume":"31","author":"MS Roh","year":"2009","unstructured":"Roh MS, Colangelo LH, O\u2019Connell MJ et al (2009) Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 31:5124\u20135130","journal-title":"J Clin Oncol"},{"key":"13_CR52","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.ijrobp.2011.01.051","volume":"82","author":"JM Samuelian","year":"2012","unstructured":"Samuelian JM, Callister MD, Ashman JB, Young-Fadok TM, Borad MJ, Gunderson LL (2012) Reduced early bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 82:1981\u20131987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13_CR53","doi-asserted-by":"crossref","unstructured":"Sauer R, Becker H, Hohenberger W et al., German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731\u20131740","DOI":"10.1056\/NEJMoa040694"},{"key":"13_CR54","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","volume":"30","author":"R Sauer","year":"2012","unstructured":"Sauer R, Liersch T, Merkel S et al (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomised phase III trial after a median follow-up of 11\u00a0years. J Clin Oncol 30:1926\u20131933","journal-title":"J Clin Oncol"},{"key":"13_CR55","doi-asserted-by":"crossref","unstructured":"Schmoll HJ, Haustermans K, Price T et al (2013) Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: response to the local treatment after chemoradiation and surgery as secondary endpoint. Ann Oncol 24:iv11\u201324","DOI":"10.1093\/annonc\/mdt201.23"},{"key":"13_CR56","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","volume":"373","author":"D Sebag-Montefiore","year":"2009","unstructured":"Sebag-Montefiore D, Stephens RJ, Steele R et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373:811\u2013820","journal-title":"Lancet"},{"key":"13_CR57","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2407-9-50","volume":"9","author":"R Siegel","year":"2009","unstructured":"Siegel R, Burock S, Wernecke KD et al (2009) Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC Cancer 9:50","journal-title":"BMC Cancer"},{"key":"13_CR58","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/1097-0142(19900701)66:1<49::AID-CNCR2820660111>3.0.CO;2-1","volume":"66","author":"Stockholm Rectal Cancer Study Group","year":"1990","unstructured":"Stockholm Rectal Cancer Study Group (1990) Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomised trial. Cancer 66:49\u201355","journal-title":"Cancer"},{"key":"13_CR59","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1056\/NEJM199704033361402","volume":"336","author":"Swedish Rectal Cancer Trial","year":"1997","unstructured":"Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980\u2013987","journal-title":"N Engl J Med"},{"key":"13_CR60","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.canrad.2010.06.017","volume":"14","author":"M Tiv","year":"2010","unstructured":"Tiv M, Puyreveau M, Mineur L et al (2010) Long-term quaity of life in patients with rectal cancer treated with preoperative (chemo)-radiotherapy within a randomized trial. Cancer Radiother 14:530\u2013534","journal-title":"Cancer Radiother"},{"key":"13_CR61","doi-asserted-by":"crossref","unstructured":"van Gijn W, Marijnen CA, Nagtegaal ID et al., Dutch Colorectal Cancer Group (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575\u201382","DOI":"10.1016\/S1470-2045(11)70097-3"},{"key":"13_CR62","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/apt.12316","volume":"37","author":"LJ Wedlake","year":"2013","unstructured":"Wedlake LJ, Shaw C, Whelan K, Andreyec HJ (2013) Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy. Aliment Pharmacol Ther 37:1046\u20131056","journal-title":"Aliment Pharmacol Ther"},{"key":"13_CR63","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.radonc.2011.10.018","volume":"102","author":"HA Wolff","year":"2012","unstructured":"Wolff HA, Wagner DM, Conradi LC et al (2012) Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: a planning study with clinical implications. Radiother Oncol 102:30\u201337","journal-title":"Radiother Oncol"},{"key":"13_CR64","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.radonc.2013.05.009","volume":"108","author":"HA Wolff","year":"2013","unstructured":"Wolff HA, Conradi LC, Beissbarth T et al (2013) Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: long-term results of the German CAO\/ARO\/AIO-94 phase III trial. Radiother Oncol 108:48\u201354","journal-title":"Radiother Oncol"}],"container-title":["Recent Results in Cancer Research","Early Gastrointestinal Cancers II: Rectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-08060-4_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T17:32:45Z","timestamp":1674149565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-08060-4_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783319080598","9783319080604"],"references-count":64,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-08060-4_13","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"8 August 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}